Predicting cooperative drug effects through the quantitative cellular profiling of response to individual drugs-Reference-Cited by-同舟云学术

Predicting cooperative drug effects through the quantitative cellular profiling of response to individual drugs

Published:2014-02 Issue:2 Volume:3 Page:102
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT: Pharmacometrics & Systems Pharmacology

Author:

Zhao J¹,Zhang X-S¹,Zhang S¹

Affiliation:

1. National Center for Mathematics and Interdisciplinary Sciences, Academy of Mathematics and Systems Science, Chinese Academy of Sciences; Beijing China

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/psp.2013.79/fullpdf

Reference38 articles.

1. The NCI60 human tumour cell line anticancer drug screen;Shoemaker;Nat. Rev. Cancer,2006

2. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease;Lamb;Science,2006

3. Discovery of drug mode of action and drug repositioning from transcriptional responses;Iorio;Proc. Natl. Acad. Sci. USA,2010

4. Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding;Iskar;Mol. Syst. Biol.,2013

5. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity;Barretina;Nature,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimalarial Drug Combination Predictions Using the Machine Learning Synergy Predictor (MLSyPred©) tool;Acta Parasitologica;2024-01-02

2. CCSynergy: an integrative deep-learning framework enabling context-aware prediction of anti-cancer drug synergy;Briefings in Bioinformatics;2022-12-23

3. Anti-Drug Response and Drug Side Effect Prediction Methods: A Review;Computational Intelligence and Data Analytics;2022-09-02

4. Predicting anti-cancer drug synergy using extended drug similarity profiles;2022-08-29

5. Cisplatin's potential for type 2 diabetes repositioning by inhibiting CDKN1A, FAS, and SESN1;Computers in Biology and Medicine;2021-08